Trial Details

COMPLETED
Basic Information
Clinical ID c1066
Identifier NCT02840721
Trial Title Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Colitis, Ulcerative
Interventions DRUG: PF-06480605
Participant Information
Sponsor Telavant, Inc.
City Aventura
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2016-10-26
Primary Completion Date 2018-05-31
Completion Date 2018-08-30